Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
210c Follow up appointments after primary hip and knee joint replacement surgery
223b Corticosteroid Injections for Patellar Tendinopathy
233c Penile Rehabilitation Following Prostate Surgery
248b Anal Irrigation
249c Anti-VEGF Treatments
250c Specialist Infant Formulas
252a TVPC 10 Non union fracture v1.0
253b Policy for the Preservation of Fertility
254b Botulinum Toxin A
255c Biologic Mesh
256b Rhinosinusitis
260a Severe and Complex Obesity
261b US Guided Injections for Hip Pain
263a Use of Biological Therapies for Ulcerative Colits
266d Sequential use of a third or subsequent biologic for psoriasis